CureRoot Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 5

CureRoot General Information

Description

Developer of a natural product drug discovery platform designed to identify novel small-molecule scaffolds from untapped botanical biodiversity for oncology and infectious disease applications. The company offers computational prioritisation, predictive ADMET modeling, automated workflows and ethnobotanical data integration with screening of African flora and validation of plant-derived metabolites through wet-lab and in vivo testing, generating therapeutic candidates for oncology indications such as pancreatic cancer and glioblastoma as well as infectious disease pipelines, enabling pharmaceutical organizations access to novel lead assets for early-stage out-licensing.

Contact Information

Website
cure-root.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 18C CSIR
  • Meiring Naude Road
  • Pretoria, Gauteng 0084
  • South Africa
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Building 18C CSIR
  • Meiring Naude Road
  • Pretoria, Gauteng 0084
  • South Africa

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CureRoot Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator Completed Startup
1. Seed Round 17-Jun-2024 Completed Startup
To view CureRoot’s complete valuation and funding history, request access »

CureRoot Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CureRoot Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Africa Health Ventures Venture Capital Minority
Alpha Gaps Venture Capital Minority
Kaleo Ventures Venture Capital Minority
OneBio Venture Studio Venture Capital Minority
Google Accelerator Accelerator/Incubator
To view CureRoot’s complete investors history, request access »

CureRoot FAQs

  • When was CureRoot founded?

    CureRoot was founded in 2023.

  • Where is CureRoot headquartered?

    CureRoot is headquartered in Pretoria, South Africa.

  • What is the size of CureRoot?

    CureRoot has 5 total employees.

  • What industry is CureRoot in?

    CureRoot’s primary industry is Drug Discovery.

  • Is CureRoot a private or public company?

    CureRoot is a Private company.

  • What is CureRoot’s current revenue?

    The current revenue for CureRoot is .

  • How much funding has CureRoot raised over time?

    CureRoot has raised $600K.

  • Who are CureRoot’s investors?

    Africa Health Ventures, Alpha Gaps, Kaleo Ventures, OneBio Venture Studio, and Google Accelerator have invested in CureRoot.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process